Abicipar Pegol Completed Phase 2 Trials for Macular Edema Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02186119
A Study of Abicipar Pegol in Patients With Diabetic Macular Edema